14 results on '"Charles T. Mupamombe"'
Search Results
2. Cardiac Involvement by HIV-Associated DLBCL
- Author
-
Charles T. Mupamombe, Jude Noel, Derek B. Laskar, and Liza Valdivia
- Subjects
Medicine - Abstract
Non-Hodgkin’s lymphoma (NHL) is a common AIDS-defining malignancy among people living with HIV. Of the different types of NHLs, diffuse large B-cell lymphoma (DLBCL) is the most common. Prognosis of DLBCL has improved over the years in the general population but remains relatively poor in HIV-positive individuals. Almost any organ system can be affected by DLBCL; however, cardiac involvement remains rare and suggests aggressive disease. We present a case of DLBCL in an HIV-positive patient, who had cardiac involvement, with the only clue to cardiac involvement being symptom being tachycardia and dysphagia.
- Published
- 2018
- Full Text
- View/download PDF
3. Assessing Efficacy and Use Patterns of Medical Cannabis for Symptom Management in Elderly Cancer Patients
- Author
-
Rachel Nathan, Charles T. Mupamombe, John Elibol, Amy A. Case, Danielle Smith, Andrew Hyland, Kristopher Attwood, and Eric D. Hansen
- Subjects
General Medicine - Abstract
Objectives Our study sought to further characterize patterns of medical cannabis use in elderly cancer patients. Furthermore, we sought to assess efficacy of medical cannabis for the treatment of pain, nausea, anorexia, insomnia and anxiety in elderly cancer patients. Background Medical cannabis use is growing for symptom management in cancer patients, but limited data exists on the safety or efficacy of use in elderly patients. Methods A retrospective chart review assessing changes in numerical symptom scores reported at clinic visits before and after medical cannabis initiation. Results There was no statistically significant difference in pain, nausea, appetite, insomnia or anxiety scores reported before and after initiation of medical cannabis. Oil was the most common form used, followed by vape, and the most common ratios used were high tetrahydrocannabinol (THC) to cannabidiol (CBD) and equal parts THC/CBD products. Conclusion This study did not find a statistically significant change in symptom scores with medical cannabis use, although further study is warranted given the limitations of the present study. Elderly patients most commonly are using equal parts THC/CBD or high THC ratio products initially.
- Published
- 2022
4. COVID-19 Pandemic Impacts on U.S. Hospice Agencies: A National Survey of Hospice Nurses and Physicians
- Author
-
Jennifer M Vanin, Charles T. Mupamombe, Janna E Baker Rogers, Jesse Thompson, Lori Constantine, and R Osvaldo Navia
- Subjects
medicine.medical_specialty ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,Health Personnel ,Home health nursing ,03 medical and health sciences ,0302 clinical medicine ,Nursing ,030502 gerontology ,Surveys and Questionnaires ,Pandemic ,Health care ,Humans ,Medicine ,030212 general & internal medicine ,Personal Protective Equipment ,Hospice care ,Emergency management ,business.industry ,Public health ,Hospices ,COVID-19 ,General Medicine ,United States ,Hospice Care ,0305 other medical science ,business - Abstract
Background: Hospice agencies face unique challenges during times of widespread public health emergencies. The pandemic of novel coronavirus disease COVID-19 is widely affecting global healthcare systems. Aim: This study assesses effects of the COVID-19 pandemic on U.S. hospice agencies, staff, and patients as reported by hospice agency staff. Design: An anonymous electronic survey was developed. Free-text comments were assessed for impacts on hospice agencies, staff, and patients and their families. Setting/Participants: The target audience was members of the American Academy of Hospice and Palliative Medicine and the Hospice and Palliative Nurses Association who self-identified as being active with hospice agencies in the United States. Results: Reported impacts include inadequate supplies of personal protective equipment, changes in hospice services, and decreased access by hospice personnel to patients in long term care facilities. Flow of patients through hospice care settings was impeded. Agencies experienced changes in workforce availability and increased emotional support needs of staff. Patient and families experienced increased bereavement needs. Nearly one-third of respondents reported negative effects on patient outcomes, such as inadequate symptom management and negative psychosocial effects. Conclusion: Respondents indicate that the COVID-19 pandemic had negative effects on both hospice patient care and hospice agency functioning. Hospice agencies appear to face challenges unique among U.S. healthcare agencies due to their service delivery model and focus on interdisciplinary care. There is need for further exploration of the effects that the COVID-19 pandemic has on hospice agencies in order to improve care for their patient population during public health emergencies.
- Published
- 2021
5. Hospice Emergency Planning and COVID-19
- Author
-
R Osvaldo Navia, Jesse Thompson, Janna E Baker Rogers, Jennifer M Vanin, and Charles T. Mupamombe
- Subjects
medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Descriptive statistics ,Emergency management ,business.industry ,SARS-CoV-2 ,Hospices ,COVID-19 ,General Medicine ,Disease ,Medicare ,Hospice and palliative medicine ,United States ,Hospice Care ,Family medicine ,Pandemic ,Medicine ,Humans ,Emergency planning ,business ,Medicaid ,Pandemics ,Aged - Abstract
Objectives: Centers for Medicare and Medicaid Services requirements for Emergency Preparedness Planning (EPP) by hospice organizations significantly increased in 2017. This study seeks to assess the involvement of various hospice personnel in EPP before and since the onset of the novel coronavirus disease COVID-19 pandemic. Methods: A link to an anonymous online survey was sent to members of the American Academy of Hospice and Palliative Medicine and the Hospice and Palliative Nurses Association, targeting members involved in hospice care in the United States. A descriptive analysis of the data was performed. Results: Prior to the pandemic, 39.8% of respondents were “moderately” or “very” involved with the development and revisions of the Emergency Preparedness Plan. Since the beginning of the pandemic, this increased to 59%, which largely occurred among physicians. Clinical Nurse and Nurse Practitioner involvement in development/revisions remained low. Approximately 30% of respondents desired more involvement across the areas of EPP. Conclusion: The involvement of personnel of various disciplines is varied and the involvement of physicians appears to have increased with the onset of the COVID-19 pandemic. A notable portion of personnel desired more involvement across all aspects of EPP. More research is needed in this important but little-understood area.
- Published
- 2021
6. Advanced‐stage hepatocellular carcinoma presenting without radiographic liver lesions
- Author
-
Arslan Ahmad, Charles T. Mupamombe, Mohan Preet, Rajesh Veluvolu, and Evelyn Taiwo
- Subjects
Gastrointestinal bleeding ,medicine.medical_specialty ,business.industry ,Radiography ,High index ,Advanced stage ,Case Report ,General Medicine ,Case Reports ,medicine.disease ,gastrointestinal hemorrhage ,digestive system diseases ,03 medical and health sciences ,0302 clinical medicine ,Text mining ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,medicine ,metastatic hepatocellular carcinoma ,030211 gastroenterology & hepatology ,In patient ,Radiology ,Metastatic hepatocellular carcinoma ,business - Abstract
Key Clinical Message In patients with known risk factors for hepatocellular carcinoma and an elevated AFP, the diagnosis should remain on the differential even in the absence of hepatic lesions. High index of suspicion is needed, and aggressive diagnostic approaches are needed to not miss this entity.
- Published
- 2018
7. Unilateral upper extremity lymphedema in metastatic prostate cancer
- Author
-
Lewis J. Kampel, Charles T. Mupamombe, Brendan LoGiurato, and Jean Marc Cohen
- Subjects
medicine.medical_specialty ,recurrence ,Case Report ,Case Reports ,Adenocarcinoma ,Malignancy ,030207 dermatology & venereal diseases ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Prostate ,medicine ,Prostate disease ,prostate ,business.industry ,cutaneous ,General Medicine ,lymphedema ,medicine.disease ,metastatic ,Lymphedema ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Radiology ,Presentation (obstetrics) ,business - Abstract
Key Clinical Message Upper extremity lymphedema and cutaneous spread are atypical behavior of prostate disease and should be kept in the differential for selected patients. This presentation in these patients may be underdiagnosed and potentially an ominous sign. Our case adds to our continued learning of possible prostate malignancy behavior.
- Published
- 2018
8. Emergency and Disaster Preparedness in Hospice and Home Health Agencies (SCI951)
- Author
-
Jennifer M Vanin, Lori Constantine, Charles T. Mupamombe, and Janna E Baker Rogers
- Subjects
Anesthesiology and Pain Medicine ,business.industry ,Home health ,Disaster preparedness ,Medicine ,Neurology (clinical) ,Medical emergency ,business ,medicine.disease ,General Nursing - Published
- 2021
9. Dexmedetomidine as an Option for Opioid Refractory Pain in the Hospice Setting
- Author
-
Christopher W. Kerr, Charles T. Mupamombe, and Debra L. Luczkiewicz
- Subjects
Adult ,Lidocaine ,Sedation ,Breast Neoplasms ,03 medical and health sciences ,0302 clinical medicine ,030502 gerontology ,Medicine ,Humans ,Ketamine ,Dexmedetomidine ,General Nursing ,Burning Pain ,business.industry ,General Medicine ,Cancer Pain ,Analgesics, Non-Narcotic ,Pain, Intractable ,Analgesics, Opioid ,Anesthesiology and Pain Medicine ,Hospice Care ,Opioid ,030220 oncology & carcinogenesis ,Anesthesia ,Delirium ,Female ,medicine.symptom ,0305 other medical science ,business ,medicine.drug ,Methadone - Abstract
Background: Opioid refractory pain is a common problem in pain management. Dexmedetomidine is suggested to have opioid-sparing effects, with well-described use in surgical and intensive care unit settings. Some authors advocate its benefit in reducing delirium. Its effects are thought to be exhibited through agonism of pre- and postsynpatic α2-receptors in the central nervous system. It is more selective on α2-receptors than clonidine, accounting for its relatively lower incidence of hypotension. Its use in sedation is favored because it does not depress the respiratory system. The main side effects reported include bradycardia. Case Description: Twenty-eight-year-old woman with triple negative left breast cancer and a locally destructive tumor was admitted to hospice after exhausting her disease-directed therapy options. Her chief complaint was a throbbing, burning pain to the left chest wall, lower back, and bilateral lower extremities, rated 8/10 on a 10-point verbal scale. Multiple pharmacologic agents for pain, including patient-controlled analgesia infusions with adjuvant methadone and steroids, had failed to provide consistent pain management. Symptoms were difficult to control in the home setting, and she required multiple admissions to our inpatient hospice unit for pain management. She also developed episodes of delirium shortly after hospice admission. We attributed her symptoms to rapid disease progression. After failed pain control with opioids, ketamine, and lidocaine, we trialed a dexmedetomidine infusion. While on the infusion, her pain rating decreased to 0/10 and she had no delirium. Pain recurred soon after cessation of the infusion, initially rated 6/10. Conclusion: Dexmedetomidine is safe for opioid refractory pain in the hospice inpatient setting. However, its effects may not be sustained. There is potential for use in end-of-life care, with added benefit for possible control of delirium.
- Published
- 2019
10. Myxedema Coma Complicated by Pancytopenia
- Author
-
Joseph Gorga, Charles T. Mupamombe, Felix Reyes, and Derek B. Laskar
- Subjects
Pediatrics ,medicine.medical_specialty ,Leukopenia ,Blood transfusion ,business.industry ,Anemia ,medicine.medical_treatment ,lcsh:R ,Levothyroxine ,Myxedema coma ,lcsh:Medicine ,Case Report ,General Medicine ,medicine.disease ,Pancytopenia ,03 medical and health sciences ,0302 clinical medicine ,Sustained response ,hemic and lymphatic diseases ,Medicine ,030212 general & internal medicine ,medicine.symptom ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Hypothyroidism is common, with an extreme manifestation of myxedema coma if untreated. Hematologic consequences of myxedema coma include mild leukopenia and anemia, rarely pancytopenia. We present a patient with typical symptoms of myxedema coma, but found to be pancytopenic, with sustained response to levothyroxine and blood transfusion for anemia.
- Published
- 2019
11. Use of medical cannabis in treating anorexia and nausea in elderly cancer patients
- Author
-
Charles T. Mupamombe, Rachel Andrea Nathan, Eric Hansen, Michelle Walter, and Amy A. Case
- Subjects
Cancer Research ,medicine.medical_specialty ,Nausea ,business.industry ,Cancer ,Anorexia ,medicine.disease ,Clinical trial ,Oncology ,Internal medicine ,Medical cannabis ,medicine ,medicine.symptom ,business ,Legalization - Abstract
124 Background: The use of medical cannabis (MC) in cancer symptom treatment has been increasing. Since its legalization is limited to select states, there are few clinical trials that have studied the effectiveness and safety of MC, and even fewer studies in the elderly patient population. Given this, we aimed to evaluate the effects of MC on nausea, appetite, and body mass index (BMI) of elderly cancer patients. Methods: We conducted a retrospective chart review of patients age 65 and older prescribed MC in the year 2018 in an outpatient palliative care clinic at a comprehensive cancer center. Nausea and appetite were measured by numerical rating (0-10) and BMI was recorded with data collected at consecutive clinic visits before and after MC use. Results: Eight-three patients aged 65 and over were included in our analysis. Half of patients were age 65-70, while 12% were age 76 or older. More than half were male (58%) and Caucasian (92%). For patients with anorexia or nausea, 58% had previously used cannabis. For nausea, 58% were prescribed ondansetron, 53% were prescribed prochlorperazine or metoclopramide, and 20% were prescribed olanzapine. For anorexia, 24% were prescribed mirtazapine, 6% were prescribed dronabinol, and 1% were prescribed megestrol. The majority of patients used oil (64%), with one-third using vape (33%) and fewer using pill (17%) and powder (5%). Patients primarily used high THC (50%) or equal THC:CBD (45%) formulations initially, with only 7% using high CBD products. The median nausea and anorexia trended towards improvement, though neither was significant (delta nausea = 0.1, p = 0.81) nor anorexia score (delta anorexia = 0.7, p = 0.69). BMI worsened despite MC use (delta BMI 1.9, p < 0.001). Conclusions: In this study of elderly patients with cancer prescribed MC, more than half had previously used cannabis. Two-thirds of patients with anorexia were using MC first-line for appetite stimulation. The majority of patients used oil, with vape next most commonly used, and the vast majority of patients using high THC or equal THC:CBD initially. Use of MC was not associated with a significant improvement in nausea nor anorexia, and BMI significantly decreased despite MC use.
- Published
- 2019
12. Efficacy of medical cannabis for cancer-related pain in the elderly: A single-center retrospective analysis
- Author
-
Rachel Andrea Nathan, Charles T. Mupamombe, Amy A. Case, Michelle Walter, and Eric Hansen
- Subjects
Cancer Research ,medicine.medical_specialty ,Oncology ,business.industry ,Family medicine ,Medical cannabis ,medicine ,Retrospective analysis ,Single Center ,business ,Cancer-Related Pain - Abstract
13 Background: Use of medical cannabis (MC) for cancer-related symptoms is growing, yet many prior studies used formulations not available in the United States (US). Clinical data on formulation, dosing and efficacy for formulations available in the US is limited. Furthermore, though interest is growing in the use of MC for elderly patients, data on safety and efficacy in this population is limited. We aimed to assess the clinical characteristics of elderly people using MC, formulations prescribed, and efficacy for cancer-related pain, insomnia and anxiety. Methods: We conducted a retrospective chart review of patients age 65 and older prescribed MC in the year 2018 in an outpatient palliative care clinic at a tertiary comprehensive cancer center. Pain intensity and anxiety were measured by numerical rating (0-10), and insomnia was assessed by self-reported hours of sleep per night, with data collected at consecutive clinic visits before and after MC use. Results: Eighty-three patients aged 65 and over were included in our analysis. Half of patients were age 65-70, while 12% were age 76 or older. Slightly more than half were male (58%), while the majority were Caucasian (92%). For patients with pain, two thirds were already prescribed opioids; 28% were using gabapentin/pregabalin, 22% duloxetine, and 7% nortriptyline/amitriptyline. Two-thirds (65%) reported never using cannabis previously. The most common MC product used was oil (35%), followed by vape (13%), pill (6%) and powder (3%). The most common initial concentrations were equal THC/CBD (41%) and high THC (43%); 8% of patients used high CBD, and 8% used a combination. The median delta pain score did not change with use of MC (delta pain = 0.0, p = 0.72), nor did anxiety (delta anxiety = -0.2, p = 1.00) nor insomnia (delta hours sleep = -0.1, p = 1.000). Conclusions: In this study of elderly patients prescribed MC, the majority of whom were cannabis naïve and already prescribed opioids, most were initially prescribed high THC or 1:1 THC/CBD, with oil and vape the most common formulations used. Use of MC was not associated with changes in pain, anxiety nor insomnia scores.
- Published
- 2019
13. Cardiac Involvement by HIV-Associated DLBCL
- Author
-
Jude Noel, Derek B. Laskar, Liza Valdivia, and Charles T. Mupamombe
- Subjects
0301 basic medicine ,Tachycardia ,Oncology ,medicine.medical_specialty ,Population ,Human immunodeficiency virus (HIV) ,MEDLINE ,lcsh:Medicine ,Case Report ,Aggressive disease ,medicine.disease_cause ,Malignancy ,03 medical and health sciences ,0302 clinical medicine ,immune system diseases ,Internal medicine ,hemic and lymphatic diseases ,medicine ,education ,neoplasms ,education.field_of_study ,business.industry ,lcsh:R ,General Medicine ,medicine.disease ,Dysphagia ,Lymphoma ,030104 developmental biology ,030220 oncology & carcinogenesis ,medicine.symptom ,business - Abstract
Non-Hodgkin’s lymphoma (NHL) is a common AIDS-defining malignancy among people living with HIV. Of the different types of NHLs, diffuse large B-cell lymphoma (DLBCL) is the most common. Prognosis of DLBCL has improved over the years in the general population but remains relatively poor in HIV-positive individuals. Almost any organ system can be affected by DLBCL; however, cardiac involvement remains rare and suggests aggressive disease. We present a case of DLBCL in an HIV-positive patient, who had cardiac involvement, with the only clue to cardiac involvement being symptom being tachycardia and dysphagia.
- Published
- 2018
14. Disease presentation and clinical outcomes of breast cancer (BC) in black women (BW) 40 yrs and under at a single urban hospital
- Author
-
Gurinder Sidhu, Sireesha Datla, Charles T. Mupamombe, Padma L. Draksharam, Harry He, and Evelyn Taiwo
- Subjects
Black women ,Cancer Research ,medicine.medical_specialty ,business.industry ,Cancer ,medicine.disease ,Surgery ,Breast cancer ,Oncology ,Disease Presentation ,Internal medicine ,medicine ,business ,Triple negative ,Urban hospital - Abstract
e12044Background: BC is the most common cancer in women of all ages; but less common under 40 years (6.6%). Younger BC patients (pts) are known to have Triple negative or Her2neu positive, advanced...
- Published
- 2016
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.